Several other equities analysts have also commented on MLAB. Zacks Investment Research raised Mesa Laboratories from a sell rating to a buy rating and set a $244.00 price target on the stock in a research note on Wednesday, August 14th. TheStreet raised Mesa Laboratories from a c+ rating to a b rating in a research note on Tuesday, July 30th. ValuEngine lowered Mesa Laboratories from a buy rating to a hold rating in a research note on Thursday, August 8th. Finally, Evercore ISI began coverage on Mesa Laboratories in a research note on Monday, August 26th. They issued an outperform rating and a $250.00 price target on the stock. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company presently has a consensus rating of Buy and a consensus price target of $247.00.
Shares of NASDAQ:MLAB opened at $243.82 on Friday. Mesa Laboratories has a 52-week low of $167.34 and a 52-week high of $268.47. The business has a fifty day moving average of $225.90 and a two-hundred day moving average of $231.62. The stock has a market cap of $928.59 million, a P/E ratio of 45.40 and a beta of 0.32. The company has a quick ratio of 1.26, a current ratio of 1.59 and a debt-to-equity ratio of 0.15.
Mesa Laboratories (NASDAQ:MLAB) last announced its quarterly earnings results on Tuesday, July 30th. The medical instruments supplier reported $1.73 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.59 by $0.14. Mesa Laboratories had a return on equity of 19.67% and a net margin of 7.53%. The business had revenue of $26.29 million for the quarter, compared to analyst estimates of $25.70 million. On average, equities analysts anticipate that Mesa Laboratories will post 7.61 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Friday, August 30th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.26%. The ex-dividend date of this dividend was Thursday, August 29th. Mesa Laboratories’s dividend payout ratio (DPR) is presently 11.92%.
Several institutional investors have recently made changes to their positions in MLAB. NEXT Financial Group Inc lifted its stake in Mesa Laboratories by 789.6% during the 2nd quarter. NEXT Financial Group Inc now owns 1,281 shares of the medical instruments supplier’s stock worth $313,000 after acquiring an additional 1,137 shares in the last quarter. Kistler Tiffany Companies LLC lifted its stake in Mesa Laboratories by 2,072.7% during the 2nd quarter. Kistler Tiffany Companies LLC now owns 29,440 shares of the medical instruments supplier’s stock worth $7,193,000 after acquiring an additional 28,085 shares in the last quarter. Arizona State Retirement System acquired a new position in Mesa Laboratories during the 2nd quarter worth about $1,344,000. Strs Ohio acquired a new position in Mesa Laboratories during the 2nd quarter worth about $733,000. Finally, Yorktown Management & Research Co Inc lifted its stake in Mesa Laboratories by 20.3% during the 2nd quarter. Yorktown Management & Research Co Inc now owns 5,000 shares of the medical instruments supplier’s stock worth $1,222,000 after acquiring an additional 843 shares in the last quarter. 90.18% of the stock is currently owned by institutional investors and hedge funds.
Mesa Laboratories Company Profile
Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.
Read More: Cash Flow
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.